-
-
-
-
-
-
-
Wolfe Research Assumes Tempus AI Inc (TEM) at Peerperform
-
-
-
-
-
-
-
Tempus AI Inc (TEM) PT Lowered to $64 at H.C. Wainwright
-
-
-
-
-
-
-
Tempus AI shows improved heart valve treatment with alerts
-
-
-
-
-
-
-
Mizuho Starts Tempus AI Inc (TEM) at Outperform
-
-
-
-
-
-
-
Tempus AI reports preliminary 2025 revenue of $1.27 billion, up 83%
-
-
-
-
-
-
-
Tempus AI, Inc (TEM) Reports Q3 Loss of $0.11, Offers Guidance
-
-
-
-
-
-
-
Ambry Genetics enhances breast cancer risk assessment tool with breast density
-
429,171 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

